BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 28529023)

  • 1. Clinical efficacy of transrectal ultrasound-guided prostate biopsy in men younger than 50 years old with an elevated prostate-specific antigen concentration (>4.0 ng/mL).
    Lu CH; Lin TP; Shen SH; Huang YH; Chung HJ; Kuo JY; Huang WJS; Wu HHH; Chang YH; Lin ATL; Chen KK
    J Chin Med Assoc; 2017 Jul; 80(7):413-418. PubMed ID: 28529023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective comparison between transrectal and transperineal prostate biopsy in the detection of prostate cancer.
    Di Franco CA; Jallous H; Porru D; Giliberto GL; Cebrelli T; Tinelli C; Rovereto B
    Arch Ital Urol Androl; 2017 Mar; 89(1):55-59. PubMed ID: 28403597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can a trained non-physician provider perform transrectal ultrasound-guided prostatic biopsies as effectively as an experienced urologist?
    Hori S; Fuge O; Trabucchi K; Donaldson P; McLoughlin J
    BJU Int; 2013 May; 111(5):739-44. PubMed ID: 22726849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
    Dell'Atti L
    J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Systematic ultrasound guided transrectal core prostate biopsy based on serum level of prostate-specific antigen].
    Yamaguchi S; Baba Y; Naito K
    Hinyokika Kiyo; 1997 Sep; 43(9):641-5. PubMed ID: 9365843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate specific antigen levels.
    Roehrborn CG; Pickens GJ; Sanders JS
    Urology; 1996 Mar; 47(3):347-52. PubMed ID: 8633400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
    Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P
    Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early diagnosis of prostate cancer in the Western Cape.
    Heyns CF; Naudé AM; Visser AJ; Marais DC; Stopforth HB; Nyarko JK; Stellmacher GA
    S Afr Med J; 2001 Aug; 91(8):679-84. PubMed ID: 11584784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of transrectal ultrasound guided biopsy in patients over 70 years old with a prostate specific Antigen (PSA) level ≤ 15 ng/ml and normal digital rectal examination: a 10-year prospective follow-up study of 427 consecutive patients.
    Mohamed ZK; Dominguez-Escrig J; Vasdev N; Bharathan B; Greene D
    Urol Oncol; 2013 Nov; 31(8):1489-96. PubMed ID: 22591749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is it effective to perform two more prostate biopsies according to prostate-specific antigen level and prostate volume in detecting prostate cancer? Prospective study of 10-core and 12-core prostate biopsy.
    Yoon BI; Shin TS; Cho HJ; Hong SH; Lee JY; Hwang TK; Kim SW
    Urol J; 2012; 9(2):491-7. PubMed ID: 22641493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of prostate cancer and changes in prostate-specific antigen (PSA) six months after surgery for benign prostatic hyperplasia in patients with elevated PSA.
    Ozden C; Inal G; Adsan O; Yazici S; Ozturk B; Cetinkaya M
    Urol Int; 2003; 71(2):150-3. PubMed ID: 12890951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤10 ng/mL.
    Hong SK; Oh JJ; Byun SS; Hwang SI; Choo MS; Lee SE
    BJU Int; 2012 Jul; 110(2 Pt 2):E81-5. PubMed ID: 22093144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of digital rectal examination, serum prostate specific antigen, and transrectal ultrasound in the detection of prostate cancer: a developing country perspective.
    Kash DP; Lal M; Hashmi AH; Mubarak M
    Asian Pac J Cancer Prev; 2014; 15(7):3087-91. PubMed ID: 24815452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic significance of prostate-specific antigen in defining indications for initial prostate biopsy].
    Popov SV; Guseinov RG; Skryabin ON; Orlov IN; Martov AG
    Urologiia; 2018 Jul; (3):92-97. PubMed ID: 30035426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical usefulness of free PSA in early detection of prostate cancer.
    Luboldt HJ; Swoboda A; Börgermann C; Fornara P; Rübben H;
    Onkologie; 2001 Feb; 24(1):33-7. PubMed ID: 11441278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prospective validation of a nomogram predictive of a positive initial prostate biopsy].
    Ramírez-Backhaus M; Bahilo P; Arlandis S; Santamaría Navarro C; Pontones Moreno JL; Jiménez-Cruz F
    Actas Urol Esp; 2010 Jan; 34(1):35-42. PubMed ID: 20223131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
    Men S; Cakar B; Conkbayir I; Hekimoglu B
    J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Echo-guided transrectal biopsy. An analysis of the results in a series of 1900 patients].
    Mayayo Dehesa T; Rodríguez-Patrón R; Zuccarino AL; Arias Funez F; Carrera Puerta C; García González R
    Arch Esp Urol; 1999 Jun; 52(5):453-63. PubMed ID: 10427883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
    Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL
    BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.
    Yli-Hemminki TH; Laurila M; Auvinen A; Määttänen L; Huhtala H; Tammela TL; Kujala PM
    BJU Int; 2013 Oct; 112(6):735-41. PubMed ID: 23746332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.